MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PTHS made $16,795K in revenue. -$43,319K in net income. Net profit margin of -257.93%.

Income Overview

Revenue
$16,795K
Net Income
-$43,319K
Net Profit Margin
-257.93%
EPS
-$23.04
Unit: Thousand (K) dollars
Revenue Breakdown
    • Net Product
    • License And Collaboration

Income Statement
2025-12-31
Total revenue
16,795
Cost of goods sold
3,988
Selling, general and administrative
42,453
Research and development
1,228
Amortization of intangible assets
1,556
Total operating expenses
49,225
Operating loss
-32,430
Interest expense
3,012
Impairment of intangible assets
285
Change in fair value of convertible debt
-14,984
Interest income and other income
5
Total other (expense) income
-18,276
Net loss before provision for income taxes
-50,706
Provision for income taxes
-7,387
Net loss
-43,319
Basic EPS
-23.04
Diluted EPS
-23.04
Basic Average Shares
1,880,498
Diluted Average Shares
1,880,498
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$43,319K Provision for income taxes-$7,387K Net loss beforeprovision for income taxes-$50,706K Net Product$16,206K License AndCollaboration$589K Operating loss-$32,430K Total other (expense)income-$18,276K Total revenue$16,795K Interest income and otherincome$5K Total operatingexpenses$49,225K Change in fair value ofconvertible debt-$14,984K Interest expense$3,012K Impairment of intangibleassets$285K Selling, general andadministrative$42,453K Cost of goods sold$3,988K Amortization of intangibleassets$1,556K Research and development$1,228K

Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS)